Juan Carlos Torre‐Alonso

Author

Also Known As

J C Torre-Alonso, J. C. TORRE-ALONSO, J. C. Torre-Alonso, J.C Torre-Alonso, J.C. Torre-Alonso, JUAN CARLOS TORRE-ALONSO, Juan C. Torre-Alonso, Juan Carlos Torre-Alonso, Juan Carlos Torre‐Alonso, Juan Torre-Alonso

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Hospital Monte Naranco Hospital Universitario Central de Asturias Hospital Universitario Fundación Alcorcón Bellvitge University Hospital Hospital General Universitario Gregorio Marañón

About

Juan Carlos Torre‐Alonso is an author at Hospital Monte Naranco specializing in medicine, rheumatology, and rheumatoid arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	225
2	Epidemiology	2	2	77
3	Public Health	1	1	51
4	Allergy	1	1	33
5	Immunology	1	1	33

Juan Carlos Torre‐Alonso

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report Pedro Zarco, Eduardo Muñóz, Xavier Juanola, Lara D. Veeken	2007	190
The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis Segundo González, Jesús Martı́nez-Borra, Juan Carlos Torre‐Alonso, Arthritis & Rheumatism	1999	147
Risk variants for psoriasis vulgaris in a large case–control collection and association with clinical subphenotypes Antonio Julià, Raül Tortosa, José Manuel Hernanz, Human Molecular Genetics	2012	101
Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Raquel Almodóvar, Loreto Carmona, Pedro Zarco, PubMed	2011	99
Psoriatic spondyloarthropathy: A comparative study between HLA-B27 positive and HLA-B27 negative disease Rubén Queiró, Cristina Sarasqueta, Joaquín Belzunegui, Seminars in Arthritis and Rheumatism Rheumatoid DisorderRheumatologyAutoimmune DiseaseSpondyloarthritisPsoriatic Spondyloarthropathy	2002	91
MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. Segundo González, Jesús Martı́nez-Borra, Antonio López‐Vázquez, PubMed	2002	81
Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations Carlos López‐Larrea, Miguel Ángel Blanco-Gelaz, Juan Carlos Torre‐Alonso, Arthritis Research & Therapy	2006	77
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis Adrià Aterido, Juan D. Cañete, Jesús Tornero, Annals of the Rheumatic Diseases	2018	75
Prevalence of Vertebral Fractures by Semiautomated Morphometry in Patients with Ankylosing Spondylitis Núria Montalá, Xavier Juanola, Eduardo Collantes‐Estévez, The Journal of Rheumatology	2011	73
Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate Jordi Gratacós, E. Casado, Jordi Real, Annals of the Rheumatic Diseases	2006	55

Page 1